[PDF] Top 20 Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Has 10000 "Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy" found on our website. Below are the top 20 most common "Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy".
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
... MS changes in our study were more than ...better central vision usually have smaller variation in MS and MD [32] and CSCR patients usually have better central vision than wet AMD ... See full document
6
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
... severe chronic central serous chorioretinopathy ...hyperautofluorescent changes in the macula together with an irregular surface of hypoautofluorescence, expanding from the fovea to the ... See full document
10
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
... with chronic CSC who received half-dose verteporfin PDT were ...(BCVA), macular sensitivity in the central 4, 8, and 12 degrees, and fixa- tion stability were evaluated at ... See full document
7
Comparing half dose photodynamic therapy with high density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
... and chronic CSC (cCSC) [1 – ...marked central vi- sion loss because of SRF leakage in the macula; this is due to a focal leak in the RPE that is visible on fluores- cein ...in chronic CSC is common ... See full document
17
<p>Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment</p>
... with central serous chorioretinopathy or age-related macular degeneration ...of central vision due to degeneration of the neural retina and retinal pigment epithelium ...Non-neovascular ... See full document
10
Efficacy of 1/3 Dose Verteporfin Photodynamic Therapy for Subacute Central Serous Chorioretinopathy
... 2003, photodynamic therapy (PDT) with full-dose verteporfin was reported as a new treatment for chronic CSC ...pigmentary changes of the RPE, and persistent choroidal ischemia can occur ... See full document
9
The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study
... Central serous chorioretinopathy was a usually self- limited condition which in general spontaneously resolves within 4–6 months; therefore observation was preferred over treatment in the first ... See full document
8
Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
... had chronic CSR treated at William Osler Health Systems, Brampton, ON, Canada between 2008 and ...of chronic CSR confirmed on fluorescein angiography; 2) persistence of SRF on optical coherence tomography ... See full document
5
Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
... Of the eight patients included in this report, there were seven males (87.5%) and one female (12.5%) with a mean age of 46.25 ± 11.18 years (range 35–70). Three right eyes (37.5%) and five left eyes (62.5%) were treated, ... See full document
6
Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report
... widely-accepted half-dose of PDT; both cases, however, instead of regressing, devel- oped CNV through the ...month after the PDT, the SRF had completely ...CSC after half-dose ... See full document
6
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
... equivalent 20/200); 2) persistent or progressive symptoms, such as visual disturbances or distortions or metamorphop- sia consistent with CSC for more than 3 months; 3) retina pigment epithelium decompensation with focal ... See full document
6
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
... mean macular sensitivities of the affected eyes were lower than the normal fellow eyes with a statistically significant difference in all areas of the study ...P,0.05). Macular thicknesses in affected eyes ... See full document
5
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
... Photodynamic therapy with verteporfin resulted in a rapid resolution of subretinal fluid in all patients as demonstrated by ...of central macular thickness between the patients with or without ... See full document
6
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
... weeks after PDT and insufficient evaluation of retinal ...sequence changes in the retina after PDT are therefore required both morphologically and functionally, allowing us to determine the mechanism ... See full document
8
Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
... months after half-dose PDT using a large spot size of 1,200 µm centered on the hyperfluorescent zones on ICGA, both SRF and intraretinal fluid on OCT had resolved completely ...reduced after ... See full document
10
Diagnostic accuracy of optical coherence tomography angiography for choroidal neovascularization: a systematic review and meta-analysis
... The sensitivity and specificity of AngioVue group were ...in sensitivity between only FA group and other reference standards group ( p < ...The sensitivity in seven other reference standards ... See full document
9
Low-dose aspirin as treatment for central serous chorioretinopathy
... 20/25–20/100). After 1 week, the difference in BCVA between the groups was still evident and statistically significant (Group A 20/36 ± 20/31, Group B 20/32 ± 20/26, P = ... See full document
5
Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports
... A 51-year-old man with no specific symptoms was re- ferred to us for incidentally found macula abnormalities during a regular checkup. He had no diabetes, hyperten- sion, underlying diseases, or family history. Bilateral ... See full document
8
Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
... vascular changes in CSC, have reported that the largest diameter of choroidal hyporeflective lumen in eyes with CSC, is not significantly enlarged compared with the fellow ... See full document
7
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
... and chronic forms of CSC with intravitreal injections of bevacizumab (Avastin) [25-28], a monoclonal antibody against VEGF, has, nevertheless, quite variable ...and macular detachment ...with chronic ... See full document
5
Related subjects